Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
Dr. Stacie Vela at the Medical University of South Carolina talks about the applications of advanced endoscopic imaging technologies in diagnosing cancer. References and Resources Chang, K. et…
Dr. Jaime Landman at Columbia University Medical Center describes a new, more insightful way to classify different types of renal cancers. References and Resources The Kidney Cancer Institute’s…
Dr. Christine Lau at the University of Virginia Health System goes over treatment options for early and late stage esophageal cancer. References and Resources Daly, J., et al.…
Christine L. Lau, MD, Assistant Professor of Surgery, University of Virginia Health System, Charlottesville, VA, goes over the procedure for diagnosing and treating esophageal cancer. References and Resources…
Pamela J. Paley, MD, Gynelcologic Oncologist, Swedish Cancer Institute, Seattle, WA, discusses minimally invasive surgery in gynecologic cancer. References and Resources Zakashansky K, Bradley WH, Nezhat FR. New…
Brenda J. Hoffman, MD, Professor, Division of Gastroenterology, Medical University of South Carolina, Charleston, SC, discusses colon cancer screening in the African-American population. References and Resources Sharma S,…
Christine L. Lau, MD, Assistant Professor of Surgery, Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia Health System, Charlottesville, VA, discusses the statistics of…
According to a small multi-center, phase II trial reported in NEJM, an investigational targeted drug for some patients with metastatic thyroid cancer can induce partial responses. References and…
The tumor-derived vaccine vitespen (Oncophage) does not prevent renal-cell carcinoma recurrence or improve survival despite promising early results. References and Resources Wood C, Srivastava P, Bukowski R, et…
Nancy A. Kernan, MD, Assistant Chief, Pediatric Bone Marrow Service, Director, Unrelated Donor Program, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the importance of SuperSibs!, a national…
